Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Vildan Kayku Liv Hospital Bahçeşehir Spec. MD. Vildan Kayku Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
15 Essential Brain Tumor MRI Scan Datasets and Images for Research
15 Essential Brain Tumor MRI Scan Datasets and Images for Research 4

Neuro-oncology is moving forward thanks to top-notch datasets, like MRI scans of brain tumors. New tools in deep learning are changing how we analyze these scans. This is helping both doctors and artificial intelligence.

Having many and well-annotated MRI datasets is key for research and better care. As the field grows, finding reliable and easy-to-get datasets is more important than ever.

Key Takeaways

  • High-quality MRI scan datasets are essential for advancing neuro-oncology research.
  • Diverse and annotated datasets support the development of AI tools.
  • Reliable datasets drive innovation and improve patient outcomes.
  • Access to extensive datasets remains a significant challenge.
  • Advancements in deep learning are transforming brain tumor analysis.

The Importance of Quality Brain Tumor MRI Scan Datasets

15 Essential Brain Tumor MRI Scan Datasets and Images for Research
15 Essential Brain Tumor MRI Scan Datasets and Images for Research 5

High-quality brain tumor MRI images are key in neuro-oncology research. They help improve clinical studies and AI in medical imaging.

Large datasets like BRISC offer 6,000 T1-weighted MRI scans with various tumor types. Public datasets like BraTS are also vital for brain tumor segmentation.

Advancing Clinical Neuro-Oncology Research

Brain tumor MRI scan datasets are vital for neuro-oncology research. They help in creating new diagnostic and treatment methods. Annotated brain tumour images MRI lead to better studies on tumors.

DatasetDescriptionSize
BRISCContrast-enhanced T1-weighted MRI scans6,000
BraTSMultimodal brain tumor segmentation datasetVaries

Fueling AI Development in Medical Imaging

Brain tumor MRI images are essential for AI in medical imaging. They help train and test AI models. This makes AI better at tumor segmentation and classification.

Using large, annotated datasets, researchers can create advanced AI models. These models improve diagnosis and support personalized medicine.

Understanding MRI Modalities in Brain Tumor Imaging

15 Essential Brain Tumor MRI Scan Datasets and Images for Research
15 Essential Brain Tumor MRI Scan Datasets and Images for Research 6

Knowing about MRI modalities is key for spotting brain tumors right and planning treatments well. MRI shows grayscale images that show different tissue types. These include proton density, FLAIR, T1-weighted, and T2-weighted images. They help doctors understand tumors and make decisions.

T1-Weighted vs. T2-Weighted Sequences

T1-weighted and T2-weighted sequences are basic in brain tumor scans. T1-weighted images show body parts clearly, and they’re better after contrast. This shows where the contrast goes, marking tumor edges. On the other hand, T2-weighted images spot water changes well, helping find swelling and lesions.

Knowing the difference between T1 and T2 images is important. Tumors look darker on T1 and brighter on T2. This helps see how big a tumor is, where it is, and if it’s spreading.

FLAIR and Contrast-Enhanced Protocols

FLAIR and contrast-enhanced scans add more to MRI’s power in brain tumor imaging. FLAIR sequences help see lesions near CSF spaces better. This is great for spotting swelling around tumors and telling it apart from fluid.

Contrast-enhanced MRI uses gadolinium to show where the blood-brain barrier is broken. This is common in brain tumors. It’s key for seeing tumor edges and how well treatments are working.

MRI ModalityPrimary Use in Brain Tumor ImagingKey Features
T1-WeightedAnatomical detail, contrast enhancementTumor appears hypointense, good for assessing tumor boundaries post-contrast
T2-WeightedDetecting edema and lesionsTumor appears hyperintense, sensitive to changes in tissue water content
FLAIRSuppressing free water signalUseful for detecting peritumoral edema and lesions near CSF spaces
Contrast-EnhancedDelineating tumor margins, assessing treatment responseHighlights areas of blood-brain barrier disruption

In summary, using T1, T2, FLAIR, and contrast-enhanced MRI gives a full view of brain tumors. Each type gives special info, helping doctors diagnose and plan treatments better.

Comprehensive Brain Tumor MRI Scan Collections

Comprehensive brain tumor MRI scan collections are key for neuro-oncology research. They give researchers the tools to create and test new ways to diagnose and treat brain tumors.

BRISC Dataset: 6,000 Annotated T1-Weighted Scans

The BRISC dataset is a big help in brain tumor research. It has 6,000 annotated T1-weighted MRI scans. This large set helps researchers train and test AI for better tumor detection and segmentation.

BraTS Challenge Dataset: Multimodal Segmentation Standard

The BraTS Challenge dataset is a top choice for testing brain tumor segmentation algorithms. It has MRI scans from different angles, like T1, T2, and FLAIR. This gives a full view of brain tumors. It also includes other CNS tumors and has datasets for both kids and adults with glioma.

TCIA Glioblastoma Collection (TCGA-GBM)

The TCIA Glioblastoma Collection, linked to TCGA-GBM, is a big help for glioblastoma research. It has lots of MRI scans with detailed clinical info. This makes it easier to study how tumors grow and how they respond to treatment.

RIDER Neuro MRI Dataset

The RIDER Neuro MRI dataset is also key for understanding brain tumors. It offers MRI scans with annotations. This helps improve automated analysis tools.

DatasetDescriptionModalities
BRISC6,000 annotated T1-weighted scansT1-weighted
BraTSMultimodal segmentation standardT1, T2, FLAIR
TCIA GlioblastomaLarge collection with clinical dataMultiple
RIDER Neuro MRIAnnotated MRI scansMultiple

These brain tumor MRI scan collections are vital for research. They offer large, detailed datasets. This helps create more accurate diagnostic tools and treatments.

Longitudinal Brain Tumor Imaging Resources

Studies using brain tumor MRI scans give us key insights. They show how tumors grow and how well treatments work. This is important for understanding tumor behavior over time.

Yale-Brain-Mets-Longitudinal: 11,892 Studies Over Two Decades

The Yale-Brain-Mets-Longitudinal dataset has 11,892 studies from 20 years. Researchers say it’s a great chance to see how brain metastases change.Check out the Yale-Brain-Mets-Longitudinal dataset for detailed research.

TCIA Collections with Temporal Progression Data

The The Cancer Imaging Archive (TCIA) has many collections. They include data on how brain tumors grow over time. These are great for those studying tumor growth and treatment effects on brain tumor images.

Harvard’s Neuroimaging Longitudinal Analysis Dataset

Harvard’s dataset is another important resource. It has MRI pictures of brain cancer taken at different times. This helps us learn more about tumor growth and improve diagnosis.

In summary, resources like Yale-Brain-Mets-Longitudinal and others are key for neuro-oncology research. They offer images for brain tumor studies. These are essential for finding better treatments.

Specialized Datasets for Tumor Classification

Specialized datasets are key in brain tumor classification research. They help create and test AI models for MRI scans. These models can accurately identify brain tumors.

Figshare Brain Tumor Classification Dataset

The Figshare Brain Tumor Classification Dataset is a great resource. It has a big collection of MRI images, all labeled and sorted. This makes it perfect for training AI to spot different brain tumors.

Key Features:

  • Large collection of MRI images
  • Meticulously labeled and categorized
  • Useful for training machine learning models

Radiopaedia’s Curated Case Collection

Radiopaedia’s Curated Case Collection is also vital. It has a wide variety of cases with detailed notes. It’s great for learning and research.

Notable aspects include:

  • Diverse range of cases
  • Detailed annotations
  • Useful for educational purposes and research

MICCAI Brain Tumor Classification Challenge Dataset

The MICCAI Brain Tumor Classification Challenge Dataset is a benchmark. It’s used in challenges to test algorithms. This helps improve brain tumor classification.

Key Benefits:

  1. Standardized dataset for evaluation
  2. Promotes advancements in brain tumor classification
  3. Used in various challenges and competitions

In conclusion, these datasets are essential for brain tumor research. They offer high-quality MRI images for better classification models.

Kaggle-Hosted Brain Tumor MRI Resources

Kaggle is a key platform for sharing brain tumor MRI datasets. It offers a wide range of resources for training AI models in brain tumor detection and classification.

7,023 Classified Images in Brain Tumor MRI Dataset

The Brain Tumor MRI Dataset on Kaggle has 7,023 classified images. It’s a big help for researchers. This dataset is key for training models to spot and classify brain tumors accurately.

Brain Tumor Detection 2020 Dataset

The Brain Tumor Detection 2020 Dataset is another great resource on Kaggle. It’s made to help develop algorithms for finding brain tumors in MRI scans.

Brain MRI Images for Brain Tumor Detection

Kaggle also has a set of Brain MRI Images for Brain Tumor Detection. This collection offers a wide range of images for training and testing brain tumor detection models.

The table below shows the main features of the Kaggle-hosted brain tumor MRI datasets:

Dataset NameNumber of ImagesPrimary Use
Brain Tumor MRI Dataset7,023Classification
Brain Tumor Detection 2020 DatasetNot specifiedDetection
Brain MRI Images for Brain Tumor DetectionNot specifiedDetection

These datasets on Kaggle are vital for brain tumor imaging research. They give researchers access to lots of MRI scans. This helps in making AI models for brain tumor diagnosis more accurate and reliable.

AI-Optimized Brain Tumor Imaging Collections

AI-optimized brain tumor imaging collections are changing neuro-oncology. They help artificial intelligence understand and analyze complex medical images better.

Advanced datasets like DeepLesion and Medical Segmentation Decathlon (MSD) lead this change. They offer large, detailed clinical data for AI model training.

DeepLesion: Large-Scale Annotated Clinical Dataset

DeepLesion has 32,735 lesions from different body parts, including the brain. It’s a great source for training AI algorithms with annotated images.

“The DeepLesion dataset has been instrumental in advancing research in medical imaging analysis, providing a large-scale resource for lesion detection and segmentation.”

MSD (Medical Segmentation Decathlon) Brain Tumor Dataset

The MSD Brain Tumor Dataset is part of a bigger challenge. It tests segmentation algorithms on various medical imaging tasks. It includes 484 multi-modal MRI scans with detailed annotations.

The MSD dataset is key for developing AI models that can accurately segment brain tumors. This is vital for treatment planning and patient care.

  • Large-scale annotated datasets for AI training
  • Multi-modal MRI scans for thorough analysis
  • Detailed annotations for precise segmentation

These AI-optimized brain tumor imaging collections are not just advancing research. They’re also making clinical practices in neuro-oncology more accurate and efficient.

Practical Considerations When Working with Brain Tumor MRI Datasets

When using brain tumor MRI datasets, several key points must be considered. These include data format, preprocessing, ethical use, and technical setup.

Data Format and Preprocessing Requirements

Brain tumor MRI data is often in DICOM or NIfTI formats. Data format standardization is vital for easy use in research. Steps like skull stripping and bias correction improve data quality.

The choice of preprocessing methods is very important. For example, skull stripping removes non-brain tissue. This helps tumor segmentation algorithms work better. It’s important to pick and test preprocessing steps carefully to keep data accurate.

Ethical Considerations and Usage Restrictions

Working with brain tumor MRI data raises big ethical considerations. Keeping patient privacy and protecting data is key. Researchers must follow rules like HIPAA in the U.S. and anonymize data properly.

Also, there are usage restrictions on some datasets, like those from clinical trials. It’s important for researchers to know and follow these rules. This keeps research ethical and legal.

Technical Infrastructure for Large-Scale Analysis

Handling big brain tumor MRI datasets needs strong technical infrastructure. This includes fast computers, lots of storage, and advanced software for analysis.

Many researchers use cloud-based solutions for MRI data analysis. These platforms offer flexible resources that grow with the project. They help teams work together more easily.

Conclusion: Future Directions in Brain Tumor Imaging Research

The future of brain tumor imaging research looks bright. It will see big steps forward with AI and large datasets. The BRISC dataset and the BraTS Challenge have already helped start this journey.

More data from different patients and imaging types will be key. This will make AI models better and more accurate. It will help doctors give better care and treatments.

AI in brain tumor research will grow fast. This is thanks to new deep learning methods and quality datasets like DeepLesion. MRI will keep playing a big role in finding new ways to understand and treat tumors.

AI, big datasets, and advanced MRI will shape the future of brain tumor imaging. They will open up new ways to find and treat tumors early.

FAQ

What is the significance of brain tumor MRI datasets in research?

Brain tumor MRI datasets are key in advancing neuro-oncology research and AI. They offer annotated MRI scans for training and validation.

What are the different MRI modalities used in brain tumor imaging?

MRI modalities include T1-weighted, T2-weighted, FLAIR, and contrast-enhanced protocols. Each provides unique information for tumor characterization.

What is the BRISC dataset, and how is it used?

The BRISC dataset is a large collection of 6,000 annotated T1-weighted MRI scans. It’s used for research in brain tumor imaging and AI development.

How do longitudinal brain tumor imaging resources contribute to research?

Longitudinal imaging resources, like the Yale-Brain-Mets-Longitudinal dataset, offer temporal progression data. This helps researchers study tumor development and treatment response over time.

What are some specialized datasets for tumor classification?

Specialized datasets include Figshare, Radiopaedia, and MICCAI challenge datasets. They provide curated MRI images for advancing classification research.

What are some practical considerations when working with brain tumor MRI datasets?

Practical considerations include data format and preprocessing, ethical considerations, and technical infrastructure for analysis.

How are AI-optimized brain tumor imaging collections used?

AI-optimized collections, like DeepLesion and MSD, are used to train AI models. These models are for tumor detection, segmentation, and classification.

What is the role of Kaggle-hosted brain tumor MRI resources?

Kaggle-hosted resources, such as the Brain Tumor MRI Dataset, provide accessible MRI images. They are for research and competition.

What is the importance of data preprocessing in brain tumor MRI analysis?

Data preprocessing is essential for ensuring data quality. It removes artifacts and standardizes formats for accurate analysis and AI model training.

How do brain tumor MRI datasets contribute to AI development in medical imaging?

Brain tumor MRI datasets contribute to AI development by providing large-scale, annotated datasets. These datasets are for training and validating AI models, leading to advancements in tumor detection, segmentation, and classification.


References

  • Menze, B. H., et al. (2015). The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS). IEEE Transactions on Medical Imaging, 34(10), 1993-2024.https://ieeexplore.ieee.org/document/6975210)
  • Ahmed, M. M., et al. (2024). Brain tumor detection and classification in MRI using hybrid deep learning CNN model. Scientific Reports, 14(1), 1-15.https://www.nature.com/articles/s41598-024-71893-3

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology

Prof. MD. Yasemin Altuner Torun

Liv Hospital Bahçeşehir
Spec. MD. Vildan Kayku Medical Oncology

Spec. MD. Vildan Kayku

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 28 17